- Home
- BSET vs CRBU Comparison
BSET vs CRBU Comparison
Compare BSET & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BSET | CRBU |
|---|---|---|
| Founded | 1902 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 169.9M | 145.8M |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BSET | CRBU |
|---|---|---|
| Price | $17.17 | $1.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $10.75 |
| AVG Volume (30 Days) | 15.0K | ★ 1.1M |
| Earning Date | 04-01-2026 | 05-08-2026 |
| Dividend Yield | ★ 5.49% | N/A |
| EPS Growth | ★ 163.06 | 3.64 |
| EPS | ★ 0.37 | N/A |
| Revenue | ★ $456,855,000.00 | N/A |
| Revenue This Year | $1.72 | $1.63 |
| Revenue Next Year | $3.78 | $10.93 |
| P/E Ratio | $46.73 | ★ N/A |
| Revenue Growth | ★ 0.96 | N/A |
| 52 Week Low | $13.17 | $1.26 |
| 52 Week High | $22.26 | $3.53 |
Technical Indicators
Market Signals| Indicator | BSET | CRBU |
|---|---|---|
| Relative Strength Index (RSI) | 34.49 | 29.82 |
| Support Level | $14.13 | N/A |
| Resistance Level | $19.31 | $1.72 |
| Average True Range (ATR) | 0.52 | 0.08 |
| MACD | -0.11 | -0.04 |
| Stochastic Oscillator | 15.87 | 4.00 |
Price Performance
Historical ComparisonAbout BSET Bassett Furniture Industries Incorporated
Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment. Majority of revenue is from Wholesale sales of furniture and accessories.
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.